Skip to main content
David Richards, DO, Cardiology, Columbus, OH, OhioHealth Riverside Methodist Hospital

DavidRRichardsDOFACC, FASE, FSCCT

Cardiology Columbus, OH

Echocardiography, Heart Failure & Transplantation, Cardiothoracic Imaging, Non-Invasive Cardiology

Chair, Department of Cardiology; Director, Cardiac CT; Lead Imaging Physician Structural Heart, Riverside Methodist Hospital

Dr. Richards is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Richards' full profile

Already have an account?

Education & Training

  • Ochsner Clinic Foundation
    Ochsner Clinic FoundationFellowship, Cardiovascular Disease, 1992 - 1996
  • Baylor College of Medicine
    Baylor College of MedicineResidency, Internal Medicine, 1989 - 1992
  • Texas College of Osteopathic Medicine
    Texas College of Osteopathic MedicineClass of 1988

Certifications & Licensure

  • OH State Medical License
    OH State License 2001 - 2026
  • TX State Medical License
    TX State License 1989 - 2009
  • LA State Medical License
    LA State License 1992 - 1996
  • Certification Board for the American Society of EchocardiographyEchocardiography
  • Certification Board for the American Society of Nuclear CardiologyNuclear Cardiology
  • Certification Board for the Society for Cardiac Computed TomographyCardiac Computed Tomography

Awards, Honors, & Recognition

  • Fellow (FASE) American Society of Echocardiography
  • FSCCT Society of Cardiac Computed Tomography
  • Fellow (FACC) American College of Cardiology

Publications & Presentations

PubMed

Journal Articles

  • Heart failure  
    Sanchez, richards, Journal of clinical outcome

Press Mentions

  • Nationwide Children's Spinoff Gets FDA OK to Test Persistent Pneumonia Treatment in Humans
    Nationwide Children's Spinoff Gets FDA OK to Test Persistent Pneumonia Treatment in HumansOctober 6th, 2022
  • Clarametyx Biosciences : Launches with an Ambitious Strategy to Address Life-Threatening Bacterial Infections
    Clarametyx Biosciences : Launches with an Ambitious Strategy to Address Life-Threatening Bacterial InfectionsMay 4th, 2020

Professional Memberships

Hospital Affiliations